Small Cell Lung Cancer Market Booms with an Influx of Companies and Robust Pipeline
Jul 3, 2020
As per DelveInsight, the Small cell lung cancer market size is expected to increase at a CAGR of 15.2% during the study period (2017–30) attributing to a rich pipeline, h...
Read More
Amylyx Raises $30M; QurAlis Announces License Agreement Deal With Lilly; COVID-19 Vaccine Updates; Researchers Develop a New Ultrafast Insulin
Jul 2, 2020
Amylyx Pharmaceuticals grabs USD 30 Million Amylyx Pharmaceuticals has grabbed USD 30 million boosts after posting positive data, which showed it could help decrease ...
Read More
Top 5 Cancers Creating Major Challenge To The Global Healthcare System
Jul 1, 2020
Over the past few decades Cancer has emerged as a major public health concern worldwide. Cancer is the second leading cause of deaths that takes place worldwide. Every sixt...
Read More
In Search for a Curative Treatment Option for Duchenne Muscular Dystrophy
Jun 29, 2020
Sarepta Therapeutics, a leading player focused in developing precision genetic medicines for rare diseases with more than 25 programs ongoing, has recently announced the su...
Read More
The Increasing Global Burden of Cytomegalovirus Seroprevalence
Jun 26, 2020
Cytomegalovirus (CMV) is a common herpes virus, and approximately 50 to 80 per cent of the adult US population has had a CMV infection by the time they turn 40. Once the vi...
Read More
Can Alzheimer’s be cured with Marijuana?
Jun 25, 2020
Alzheimer’s is a progressive brain disorder that results in the degeneration of brain cells. It affects thinking, reasoning, memory, and problem solving skills of the...
Read More
Sarepta & Codiak Inks $72.5M Deal; Invitae to Acquires ArcherDX; Merck announces V114’s Phase III result
Jun 25, 2020
Sarepta Therapeutics has announced a research and option alliance with Codiak BioSciences to design and develop engineered exosome therapeutics for neuromuscular diseases T...
Read More
Mapping The Pipeline Development In The Geographic Atrophy Market
Jun 25, 2020
The Geographic atrophy market size is anticipated to increase during the study period 2017–2030 owing to increasing GA prevalence, better understanding of disease pathoph...
Read More
Paradigm Shift In The Diabetic Peripheral Neuropathy Market Landscape As The Focus Shifts Towards The Cure
Jun 19, 2020
Diabetic Peripheral Neuropathy Market is anticipated to grow with a CAGR of 12% by 2030 attributed to increasing DPN prevalence, and introduction to gene therapies in the p...
Read More
The Question That Remains Unanswered: What Might Be Causing Alzheimer’s?
Jun 25, 2020
50 million people globally have dementia, and out of all the dementia cases, Alzheimer’s Disease accounts for about 60–70% of cases, says the WHO. Alzheimer’s Dis...
Read More
How are Diabetic Peripheral Neuropathy medications changing the DPN market scenario?
Jun 15, 2020
Diabetic Peripheral Neuropathy Market is anticipated to grow with a CAGR of 12% for the study period of 2017-2030 Diabetic Peripheral Neuropathy (DPN) or Distal Symmetric P...
Read More
The Puzzle Of So-Called Alzheimer’s
Jun 14, 2020
Alzheimer’s Disease Market size shall grow during the forecast period, owing to the launch of upcoming therapies, better understanding and better awareness. Demograph...
Read More
AbbVie & Genmab’s Collaboration; Lilly’s antisense neuro deal; COVID-19 treatment updates; Roche’s partnership with Innovent;
Jun 15, 2020
AbbVie Seals a USD 750 M Bispecific Antibody Cancer Drug Deal with Genmab AbbVie is set to reimburse Genmab USD 750 million upfront for a stake in a pipeline of...
Read More
When Technological Innovations Help in Remembering for People Living with Alzheimer’s
Jun 10, 2020
Alzheimer’s is a progressive neurological disorder associated with the degeneration of brain cells with time. As the disease progresses it causes severe impact on the...
Read More
With the Advances in Regenerative Therapy to Offer Curated Treatment Options, Off-label Therapy Market is Set to Decline for Dilated Cardiomyopathy
Jun 24, 2020
The Dilated Cardiomyopathy Market Size in the 7MM is expected to increase at a CAGR of 13.1% for the study period 2017-30. Dilated Cardiomyopathy (DCM) is one of the most c...
Read More
